Join Strategic Legislative Affairs Manager Alicia Prygoski for Lobbying for Animals: State & Federal Legislative Update, a discussion about the legislative progress we’ve made for animals this year. Learn about the bills we’ve worked to pass in 2022 to protect farmed animals, wildlife, companion animals, and more – and what we anticipate working on in state capitols and at the federal level as we approach the new year. We’ll also explore how you can directly impact the legislative process to make a difference for animals. A brief Q&A will follow the presentation.
This webinar was recorded on December 6, 2022.
Resources
- Find your elected officials
- Model Animal Protection Laws
- Sign up to receive action alerts
- Learn more about our Legislative Affairs Program
- Big Cat Public Safety Act (S. 1210/H.R 263)
- Captive Primate Safety Act (S. 1588/H.R. 3135)
- Farm System Reform Act (HR 4421/S 2332)
- Animal Welfare Enforcement Improvement Act (HR 2377)
- Goldie’s Act (HR 6100)
- OPPOSE: Livestock Regulatory Protection Act (S 1475)
- Factory farm biogas
- Lobbying for Animals: State & Federal Legislative Update – PPT Presentation (PDF)
-
Alicia Prygoski
Strategic Legislative Affairs Manager
Sign Up!
Join the Animal Legal Defense Fund's email list to stay up to date on lawsuits, legislation, and regulations affecting animals.
How We Work
Related
-
Animal Legal Defense Fund Grant Supported Washington Attorney General’s Enforcement of Animal Cruelty Law
The judge sentenced a Snohomish County resident for killing then displaying neighborhood wildlife and shooting a kitten in the eye.April 18, 2024 News -
REPORT: 95 Percent of Consumers Prefer “Climate-Friendly” Products, But Labels Oversell Emission Reductions
New report reveals how misleading labels lead to increased confusion among consumers searching for more sustainable, less environmentally damaging products.April 2, 2024 Press Release -
Lawsuit Filed Demanding FDA Respond to Petitions Seeking to Ban Ractopamine
FDA’s approval for ractopamine relied primarily on safety studies conducted by the drugmaker.March 26, 2024 Press Release